Michela Ballardini

Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1

S. Pecorelli, G. Favalli, Angiolo Gadducci et al. · Journal of Clinical Oncology · 2009 · 113 citations

Second-line high-dose chemotherapy in patients with mediastinal and retroperitoneal primary non-seminomatous germ cell tumors: the EBMT experience

Ugo De Giorgi, T. Demirer, H. Wandt et al. · Annals of Oncology · 2004 · 69 citations · Full text

Second-line High-dose Chemotherapy, Urology, Surgical Oncology +9

Activity of chemotherapy in mucinous ovarian cancer with a recurrence free interval of more than 6 months: results from the SOCRATES retrospective study

Sandro Pignata, Gabriella Ferrandina, Giovanna Scarfone et al. · BMC Cancer · 2008 · 50 citations · Full text

The palliative prognostic score and survival in patients with advanced solid tumors receiving chemotherapy

Davide Tassinari, Luigi Montanari, Marco Maltoni et al. · Supportive Care in Cancer · 2007 · 48 citations

Palliative Care, Palliative Prognostic Score, Prognostic Evaluation +7

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients

Ruggero Ridolfi, Massimiliano Petrini, Laura Fiammenghi et al. · Journal of Translational Medicine · 2006 · 42 citations · Full text